🔗 Permalink

Inventor profile of:

John F.W. Keana

City:

Eugene, Oregon

Country:

United States

Published Applications:

Last publication date:

2021-05-20

Top Assignees for applications by John F.W. Keana

The entities that hold a legal rights for patent applications filed by inventor Keana John F.W.:

Salk Institute for Biological Studies 7 La Jolla, CA United States
The University of Sydney 4 Sydney, Australia
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 4 La Jolla, CA United States
Mitobridge, Inc. 3 Cambridge, MA United States
SYNDAX PHARMACEUTICALS, INC. 2 San Diego, CA United States
UNIVERSITY OF SYDNEY 2 Sydney, Australia
Cascade Prodrug Inc. 2 Eugene, OR United States
Stat of Oregon Acting by and Through The Oregon State Board of Higher Education on Behalf of the University of Oregon 1 Eugene, OR United States
THE UNIVERSITY OF SYDNEY 1 New South Wales, Australia
THE UNIVERSITY OF SYDNEY 1 Sydney, New South Wales, Australia
University of Oregon 1 Eugene, OR United States
Regents of the University of Michigan 1 Ann Arbor, MI United States
THE REGENTS OF THE UNIVERSITY OF MICHIGAN 1 Ann Arbor, MI United States
Salk Institute for Biological Studies 1 La Jolla, MA United States
State of Oregon Acting By and Through The Oregon State Board of Higher Education On Behalf of The U 1 Eugene, OR United States

Recent patent applications by Keana John F.W.

John F.W. Keana from Eugene, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-05-20

US20210147365A1

Chemistry; metallurgy

Analogs of fexaramine and methods of making and using

#2 | 2020-06-18

US20200190019A1

Chemistry; metallurgy

PPAR agonists

#3 | 2020-04-23

US20200123113A1

Chemistry; metallurgy

Analogs of fexaramine and methods of making and using

#4 | 2019-03-21

US20190084939A1

Chemistry; metallurgy

Analogs of fexaramine and methods of making and using

#5 | 2018-06-21

US20180170857A1

Chemistry; metallurgy

PPAR agonists

#6 | 2017-03-09

US20170066724A1

Chemistry; metallurgy

Analogs of fexaramine and methods of making and using

#7 | 2016-12-29

US20160376279A1

Chemistry; metallurgy

FXR agonists and methods for making and using

#8 | 2016-01-28

US20160023991A1

Chemistry; metallurgy

PPAR agonists

#9 | 2012-05-03

US20120107230A1

Chemistry; metallurgy

Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs

#10 | 2010-11-25

US20100298270A1

Chemistry; metallurgy

Novel Compounds and Methods of Using Them

#11 | 2010-10-21

US20100267779A1

Chemistry; metallurgy

Novel Compounds and Methods of Using Them

#12 | 2010-01-21

US20100016252A1

Chemistry; metallurgy

Mannich base N-oxide drugs

#13 | 2008-12-11

US20080305082A1

Chemistry; metallurgy

1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof

#14 | 2008-12-11

US20080305075A1

Chemistry; metallurgy

Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs

#15 | 2008-03-20

US20080070934A1

Chemistry; metallurgy

KW-3902 CONJUGATES THAT DO NOT CROSS THE BLOOD-BRAIN BARRIER

#16 | 2008-01-24

US20080021110A1

Chemistry; metallurgy

Production of gossypol co-crystals

#17 | 2005-09-01

US20050192231A1

Chemistry; metallurgy

Dipeptide apoptosis inhibitors and the use thereof

InventorID:

1422919 ⎘